Symbol="FDMT"
AssetType="Common Stock"
Name="4D Molecular TherapeuticsÂ Inc"
Description="4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops candidate products using its adeno-associated virus vectors. The company is headquartered in Emeryville, California."
CIK="1650648"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="5858 HORTON STREET #455, EMERYVILLE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="794985000"
EBITDA="-110720000"
PERatio="None"
PEGRatio="None"
BookValue="6.58"
DividendPerShare="0"
DividendYield="0"
EPS="-3.37"
RevenuePerShareTTM="0.068"
ProfitMargin="0"
OperatingMarginTTM="-51.52"
ReturnOnAssetsTTM="-0.25"
ReturnOnEquityTTM="-0.427"
RevenueTTM="2208000"
GrossProfitTTM="-77124000"
DilutedEPSTTM="-3.37"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.756"
AnalystTargetPrice="38.63"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="378.9"
PriceToBookRatio="3.014"
EVToRevenue="277.01"
EVToEBITDA="-5.32"
Beta="2.354"
num_52WeekHigh="26.49"
num_52WeekLow="6.58"
num_50DayMovingAverage="18.57"
num_200DayMovingAverage="17.39"
SharesOutstanding="41885400"
DividendDate="None"
ExDividendDate="None"
symbol="FDMT"
open="19.14"
high="19.85"
low="18.76"
price="19.76"
volume="361608.00"
latest_trading_day="2023-07-11"
previous_close="18.76"
change="1.00"
change_percent="5.3305%"
aroon_positive_momentum_days="20"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="20"
Volume_recent_avg="565093"
Change_recent_avg="0.01"
Delta_recent_avg="1.37"
Variance_recent_avg="0.68"
Change_ratio_recent_avg="-0.11"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="20"
Aroon_momentum_negative="80"
image_negative_thumbnail_id_1="489"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0116.jpeg"
image_negative_thumbnail_id_2="1118"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0151.jpeg"
image_neutral_thumbnail_id_1="532"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_neutral_thumbnail_id_2="556"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_positive_thumbnail_id_1="993"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_positive_thumbnail_id_2="985"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0147.jpeg"
image_professor_thumbnail_id_1="1201"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
